| 000 | 01751 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515072951.0 | ||
| 264 | 0 | _c20071001 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0277-3740 | ||
| 024 | 7 |
_a10.1097/ICO.0b013e31805290ce _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrattler, William | |
| 245 | 0 | 0 |
_aDouble-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. _h[electronic resource] |
| 260 |
_bCornea _cJul 2007 |
||
| 300 |
_a665-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzeneacetamides _xadministration & dosage |
| 650 | 0 | 4 |
_aCornea _xsurgery |
| 650 | 0 | 4 |
_aCorneal Opacity _xchemically induced |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperopia _xsurgery |
| 650 | 0 | 4 | _aKeratomileusis, Laser In Situ |
| 650 | 0 | 4 |
_aKetorolac Tromethamine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyopia _xsurgery |
| 650 | 0 | 4 |
_aOphthalmic Solutions _xadministration & dosage |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPain, Postoperative _xdrug therapy |
| 650 | 0 | 4 |
_aPhenylacetates _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 650 | 0 | 4 |
_aWound Healing _xdrug effects |
| 700 | 1 | _aMcDonald, Marguerite | |
| 773 | 0 |
_tCornea _gvol. 26 _gno. 6 _gp. 665-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ICO.0b013e31805290ce _zAvailable from publisher's website |
| 999 |
_c17129258 _d17129258 |
||